Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Native Extracts is an Australian phytotechnology company specializing in the development and manufacture of high-performance botanical extracts for the cosmetic, nutraceutical, and pharmaceutical industries. Founded in 2012 by Lisa Carroll, the company pioneered "Cellular Extraction™," a proprietary technology that uses high pressure and rapid extraction to harness a plant's complete water-soluble phyto-compound profile (the "entourage") without degrading the biomatrix. Their extensive library, often referred to as the "Australian Pharmacopoeia," includes unique extracts from Australian native species like Kakadu Plum, Finger Lime, and Davidson Plum. Native Extracts provides traceable, transparent, and eco-sustainable ingredients to global brands, bridging the gap between traditional botanical knowledge and modern scientific validation. The company operates an ISO 9001:2015 certified manufacturing facility in New South Wales and maintains strong partnerships with Indigenous growers to ensure ethical sourcing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Native Extracts.